Litigation

Recent Posts

$2.36B Glaxo Charge Covers Avandia, Paxil Litigation, Other Legal Costs
Posted on 15 Jul 2010 by Tom Moylan

LONDON - (Mealey's) GlaxoSmithKline PLC (GSK) on July 15 said it expects to take a $2.36 billion charge against earnings to settle several legal issues, including settling "the substantial majority" of Avandia product liability cases and... Read More

Tags: diabetes drug , Mealey’s , drugs , drugs & devices , U.S. Securities and Exchange Commission , personal injury , Paxil , paroxetine , product liability , Apotex , Litigation , GSK , GlaxoSmithKline , lawsuit , Glaxo , antidepressant , torts , Avandia